Bloodstream infections in febrile neutropenic patients at a tertiary care center in Lebanon: a view of the past decade

International Journal of Infectious Diseases

Volumn 11, Issue 5, 2007, Pages 450-453

  Kanafani, Zeina A ^a   Dakdouki, Ghenwa K ^b   El Chammas, Khalil I ^c   Eid, Shaker ^c   Araj, George F ^c   Kanj, Souha S ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Hammoud Hospital   (Lebanon)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Bacteremia; Gram negative infection; Lebanon; Neutropenic fever

Indexed keywords

CEFEPIME; CEFTAZIDIME; FLUCONAZOLE; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL INFECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; DEVELOPING COUNTRY; DISEASE SURVEILLANCE; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL INFECTION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HEALTH CARE DELIVERY; HIGH RISK PATIENT; HUMAN; INFECTION RATE; LEBANON; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OBSERVATIONAL STUDY; PATIENT CARE; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PYREXIA IDIOPATHICA; SEPSIS; TERTIARY HEALTH CARE;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; COHORT STUDIES; FEMALE; FEVER; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LEBANON; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES;

EID: 34547727391     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2006.12.008     Document Type: Article

References (22)

1. Viscoli C., Varnier O., and Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis 40 Suppl 4 (2005) S240-S245
2. Klastersky J. Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis 39 Suppl 1 (2004) S32-S37
3. Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 39 Suppl 1 (2004) S25-S31
4. Ghosn M., Dagher E., Nasr F., Chahine G., Taleb N., Nasnas R., et al. Infections in cancer patients with granulocytopenia. Retrospective studies of 59 febrile episodes with hospitalization. J Med Liban 42 (1994) 117-122
5. Hamzeh F., Kanj S.S., and Uwaydah M. Febrile neutropenia in cancer patients in a tertiary care medical center in Lebanon: microbial spectrum and outcome. J Med Liban 48 (2000) 136-142
6. Kanj S.S., Adel N., and Araj G.F. The continued prevalence of Gram-negative infections in febrile neutropenic patients in Lebanon. Comparison with studies from the Middle East. BMJ (Middle East) 8 (2001) 6-13
7. Hughes W.T., Armstrong D., Bodey G.P., Bow E.J., Brown A.E., Calandra T., et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34 (2002) 730-751
8. Oppenheim B.A. The changing pattern of infection in neutropenic patients. J Antimicrob Chemother 41 Suppl D (1998) 7-11
9. Zinner S.H. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on Gram-positive and resistant bacteria. Clin Infect Dis 29 (1999) 490-494
10. Aksu G., Ruhi M.Z., Akan H., Bengisun S., Ustun C., Arslan O., et al. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants. Bone Marrow Transplant 27 (2001) 201-205
11. Gaytan-Martinez J., Mateos-Garcia E., Sanchez-Cortes E., Gonzalez-Llaven J., Casanova-Cardiel L.J., and Fuentes-Allen J.L. Microbiological findings in febrile neutropenia. Arch Med Res 31 (2000) 388-392
12. Haupt R., Romanengo M., Fears T., Viscoli C., and Castagnola E. Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution. Eur J Cancer 37 (2001) 2413-2419
13. Jones R.N., Beach M.L., and Pfaller M.A. Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!. Diagn Microbiol Infect Dis 41 (2001) 161-163
14. Raje N.S., Rao S.R., Iyer R.S., Kelkar R.S., Pai S.K., Nair C.N., et al. Infection analysis in acute lymphoblastic leukemia: a report of 499 consecutive episodes in India. Pediatr Hematol Oncol 11 (1994) 271-280
15. al-Bahar S., Pandita R., Dhabhar B.N., and al-Bahar E. Febrile neutropenia in cancer patients in Kuwait: microbial spectrum and outcome. Support Care Cancer 2 (1994) 400-402
16. al-Fawaz I.M., Kambal A.M., al-Rabeeah A.A., al-Rasheed S.A., al-Eissa Y.A., and Familusi J.B. Septicaemia in febrile neutropenic children with cancer in Saudi Arabia. J Hosp Infect 18 (1991) 307-312
17. Mahmood S., Revesz T., and Mpofu C. Febrile episodes in children with cancer in the United Arab Emirates. Pediatr Hematol Oncol 13 (1996) 135-142
18. Santhosh-Kumar C.R., Ajarim D.S., Harakati M.S., al Momen A.K., al Mohareb F., and Zeitany R.G. Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia. J Infect 25 (1992) 11-19
19. Khan M.A., Siddiqui B.K., Shamim A., Yosuf M.A., Ahmed U., Zakiullah N., et al. Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan. J Pak Med Assoc 54 (2004) 357-360
20. Kanafani Z.A., Mehio-Sibai A., Araj G.F., Kanaan M., and Kanj S.S. Epidemiology and risk factors for extended-spectrum beta-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon. Am J Infect Control 33 (2005) 326-332
21. Cherif H., Bjorkholm M., Engervall P., Johansson P., Ljungman P., Hast R., et al. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies. Scand J Infect Dis 36 (2004) 593-600
22. Rossini F., Terruzzi E., Verga L., Larocca A., Marinoni S., Miccolis I., et al. A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia. Support Care Cancer 13 (2005) 387-392